JP2011519960A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011519960A5 JP2011519960A5 JP2011508768A JP2011508768A JP2011519960A5 JP 2011519960 A5 JP2011519960 A5 JP 2011519960A5 JP 2011508768 A JP2011508768 A JP 2011508768A JP 2011508768 A JP2011508768 A JP 2011508768A JP 2011519960 A5 JP2011519960 A5 JP 2011519960A5
- Authority
- JP
- Japan
- Prior art keywords
- angiogenin
- prophylactic
- agent according
- muscular dystrophy
- therapeutic agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102100022987 Angiogenin Human genes 0.000 claims 8
- 108010072788 angiogenin Proteins 0.000 claims 8
- 239000003814 drug Substances 0.000 claims 5
- 230000000069 prophylactic effect Effects 0.000 claims 5
- 229940124597 therapeutic agent Drugs 0.000 claims 5
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims 4
- 102000016970 Follistatin Human genes 0.000 claims 3
- 108010014612 Follistatin Proteins 0.000 claims 3
- 208000001132 Osteoporosis Diseases 0.000 claims 3
- 239000003795 chemical substances by application Substances 0.000 claims 3
- 201000000585 muscular atrophy Diseases 0.000 claims 3
- 238000011321 prophylaxis Methods 0.000 claims 3
- 102000004877 Insulin Human genes 0.000 claims 2
- 108090001061 Insulin Proteins 0.000 claims 2
- 206010028289 Muscle atrophy Diseases 0.000 claims 2
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 claims 2
- 230000001419 dependent effect Effects 0.000 claims 2
- 206010012601 diabetes mellitus Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 208000035475 disorder Diseases 0.000 claims 2
- 229940125396 insulin Drugs 0.000 claims 2
- 201000006938 muscular dystrophy Diseases 0.000 claims 2
- 230000001314 paroxysmal effect Effects 0.000 claims 2
- 208000000103 Anorexia Nervosa Diseases 0.000 claims 1
- 206010003694 Atrophy Diseases 0.000 claims 1
- 241000283690 Bos taurus Species 0.000 claims 1
- 206010006895 Cachexia Diseases 0.000 claims 1
- 208000037141 Congenital muscular dystrophy, Fukuyama type Diseases 0.000 claims 1
- 208000035810 Denervation atrophy Diseases 0.000 claims 1
- 206010013801 Duchenne Muscular Dystrophy Diseases 0.000 claims 1
- 201000006813 Fukuyama congenital muscular dystrophy Diseases 0.000 claims 1
- 208000002705 Glucose Intolerance Diseases 0.000 claims 1
- 206010022489 Insulin Resistance Diseases 0.000 claims 1
- 201000009342 Limb-girdle muscular dystrophy Diseases 0.000 claims 1
- 208000029725 Metabolic bone disease Diseases 0.000 claims 1
- 208000021642 Muscular disease Diseases 0.000 claims 1
- 206010028372 Muscular weakness Diseases 0.000 claims 1
- 206010028629 Myoglobinuria Diseases 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 206010049088 Osteopenia Diseases 0.000 claims 1
- 206010033799 Paralysis Diseases 0.000 claims 1
- 208000005770 Secondary Hyperparathyroidism Diseases 0.000 claims 1
- 206010047626 Vitamin D Deficiency Diseases 0.000 claims 1
- 201000006793 Walker-Warburg syndrome Diseases 0.000 claims 1
- 239000003098 androgen Substances 0.000 claims 1
- 230000037444 atrophy Effects 0.000 claims 1
- 230000003796 beauty Effects 0.000 claims 1
- 230000009286 beneficial effect Effects 0.000 claims 1
- 210000000988 bone and bone Anatomy 0.000 claims 1
- 208000003295 carpal tunnel syndrome Diseases 0.000 claims 1
- 230000009693 chronic damage Effects 0.000 claims 1
- 208000016097 disease of metabolism Diseases 0.000 claims 1
- 230000001815 facial effect Effects 0.000 claims 1
- 230000006589 gland dysfunction Effects 0.000 claims 1
- 239000003862 glucocorticoid Substances 0.000 claims 1
- 201000001421 hyperglycemia Diseases 0.000 claims 1
- 208000014674 injury Diseases 0.000 claims 1
- 230000007774 longterm Effects 0.000 claims 1
- 230000007246 mechanism Effects 0.000 claims 1
- 208000030159 metabolic disease Diseases 0.000 claims 1
- 239000008267 milk Substances 0.000 claims 1
- 210000004080 milk Anatomy 0.000 claims 1
- 235000013336 milk Nutrition 0.000 claims 1
- 210000003205 muscle Anatomy 0.000 claims 1
- 230000020763 muscle atrophy Effects 0.000 claims 1
- 230000003387 muscular Effects 0.000 claims 1
- 208000025855 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4 Diseases 0.000 claims 1
- 230000036473 myasthenia Effects 0.000 claims 1
- 206010028417 myasthenia gravis Diseases 0.000 claims 1
- 208000018360 neuromuscular disease Diseases 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 210000000056 organ Anatomy 0.000 claims 1
- 201000008482 osteoarthritis Diseases 0.000 claims 1
- 208000021090 palsy Diseases 0.000 claims 1
- 230000000737 periodic effect Effects 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 201000009104 prediabetes syndrome Diseases 0.000 claims 1
- 230000002028 premature Effects 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 208000001076 sarcopenia Diseases 0.000 claims 1
- 208000000943 scapulohumeral muscular dystrophy Diseases 0.000 claims 1
- 230000001629 suppression Effects 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 230000008733 trauma Effects 0.000 claims 1
- 230000008736 traumatic injury Effects 0.000 claims 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 1
- 230000029663 wound healing Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2008902371A AU2008902371A0 (en) | 2008-05-14 | Oral preparation | |
| AU2008902371 | 2008-05-14 | ||
| PCT/AU2009/000602 WO2009137879A1 (en) | 2008-05-14 | 2009-05-14 | Orally administrable dosage forms comprising angiogenin and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011519960A JP2011519960A (ja) | 2011-07-14 |
| JP2011519960A5 true JP2011519960A5 (enExample) | 2012-06-21 |
Family
ID=41318285
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011508768A Pending JP2011519960A (ja) | 2008-05-14 | 2009-05-14 | アンギオゲニンを含む経口投与可能な投与形態物及びその使用 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20110262422A1 (enExample) |
| EP (1) | EP2307044A4 (enExample) |
| JP (1) | JP2011519960A (enExample) |
| KR (1) | KR20110033122A (enExample) |
| CN (1) | CN102099050A (enExample) |
| AU (1) | AU2009246052A1 (enExample) |
| BR (1) | BRPI0911958A2 (enExample) |
| CA (1) | CA2724048A1 (enExample) |
| IL (1) | IL209284A0 (enExample) |
| MX (1) | MX2010012438A (enExample) |
| NZ (1) | NZ589306A (enExample) |
| RU (1) | RU2010150934A (enExample) |
| WO (1) | WO2009137879A1 (enExample) |
| ZA (1) | ZA201009004B (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101760758B1 (ko) * | 2008-05-14 | 2017-07-24 | 애그리컬쳐 빅토리아 서비스 피티와이 엘티디 | 질병 및 장애를 치료하기 위한 안지오게닌 또는 안지오게닌 아고니스트의 이용 |
| CA2818467A1 (en) * | 2009-11-18 | 2011-05-26 | Murray Goulburn Co-Operative Co. Limited | Recombinant microorganisms |
| US20120328591A1 (en) * | 2009-11-18 | 2012-12-27 | Agriculture Victoria Services Pty Ltd | Methods for improving oral delivery |
| WO2011060489A1 (en) * | 2009-11-18 | 2011-05-26 | Murray Goulburn Co-Operative Co. Limited | Transgenic non-human animals |
| WO2011113100A1 (en) * | 2010-03-17 | 2011-09-22 | Murray Goulburn Co-Operative Co. Limited | Method of treating a bone disorder |
| AU2013204740C1 (en) * | 2012-05-10 | 2015-10-01 | Agriculture Victoria Services Pty Ltd | Methods of treating cancer using angiogenin or an angiogenin agonist |
| WO2014020676A1 (ja) * | 2012-07-31 | 2014-02-06 | 雪印メグミルク株式会社 | 新規タンパク質素材 |
| JP6140162B2 (ja) * | 2012-07-31 | 2017-05-31 | 雪印メグミルク株式会社 | 骨強化用粉乳組成物及びその製造方法 |
| AU2012386764B2 (en) * | 2012-07-31 | 2016-05-05 | Megmilk Snow Brand Co., Ltd. | Powdered milk product, and method for producing same |
| MX2015001340A (es) * | 2012-07-31 | 2015-09-04 | Megmilk Snow Brand Co Ltd | Producto novedoso de leche fermentada y metodo para preparar el mismo. |
| KR101996117B1 (ko) * | 2012-07-31 | 2019-07-03 | 유키지루시 메그밀크 가부시키가이샤 | 음료 및 그 제조 방법 |
| AU2012386761B2 (en) | 2012-07-31 | 2016-05-05 | Megmilk Snow Brand Co., Ltd. | Beverage, and method for producing same |
| KR20150036687A (ko) * | 2012-07-31 | 2015-04-07 | 유키지루시 메그밀크 가부시키가이샤 | 치즈류 및 그 제조 방법 |
| AU2012386763B2 (en) | 2012-07-31 | 2016-05-05 | Megmilk Snow Brand Co., Ltd. | Fermented milk product, and method for producing same |
| AU2012386758C1 (en) * | 2012-07-31 | 2017-03-30 | Megmilk Snow Brand Co., Ltd. | Novel protein material |
| JP2016152809A (ja) * | 2016-04-05 | 2016-08-25 | 雪印メグミルク株式会社 | 飲料及びその製造方法 |
| JP6562956B2 (ja) * | 2017-02-28 | 2019-08-21 | 雪印メグミルク株式会社 | 飲料及びその製造方法 |
| JP6357266B2 (ja) * | 2017-06-07 | 2018-07-11 | 雪印メグミルク株式会社 | 骨疾患の予防又は治療用タンパク質素材 |
| JP6357265B2 (ja) * | 2017-06-07 | 2018-07-11 | 雪印メグミルク株式会社 | 骨疾患の予防又は治療用タンパク質素材 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2947657B2 (ja) * | 1991-02-27 | 1999-09-13 | 森永乳業株式会社 | 神経成長因子産生促進剤 |
| JP3929088B2 (ja) * | 1996-06-20 | 2007-06-13 | 雪印乳業株式会社 | 骨形成促進及び骨吸収防止剤 |
| JPH10139682A (ja) * | 1996-11-14 | 1998-05-26 | Mitsubishi Chem Corp | 骨吸収促進剤 |
| CN1761463A (zh) * | 2003-03-17 | 2006-04-19 | 日本烟草产业株式会社 | 提高s-[2-([[1-(2-乙基丁基)环己基]羰基]氨基)苯基]-2-甲基丙硫代酸酯口服生物利用度的方法 |
| JP4698935B2 (ja) * | 2003-05-07 | 2011-06-08 | 雪印乳業株式会社 | 皮膚コラーゲン産生促進剤 |
| WO2004106491A2 (en) * | 2003-05-22 | 2004-12-09 | The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Angiogenin-based hiv-1 therapies |
| US20050180957A1 (en) * | 2004-01-16 | 2005-08-18 | Scharp David W. | Method of using fibrin-bound angiogenic factors to stimulate vascularization of transplant site of encapsulated cells |
| GB0425625D0 (en) * | 2004-11-22 | 2004-12-22 | Royal College Of Surgeons Ie | Treatment of disease |
| WO2007023479A2 (en) * | 2005-08-23 | 2007-03-01 | Royal College Of Surgeons In Ireland | Treatment of central nervous system injury |
| US8021659B2 (en) * | 2006-04-28 | 2011-09-20 | Naidu Lp | Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof |
| US20070275036A1 (en) * | 2006-05-18 | 2007-11-29 | Celldyne Biopharma, Llc | Avian follistatin product |
| US8551547B2 (en) * | 2006-11-10 | 2013-10-08 | Murray Goulburn Co-Operative Co., Limited | Process for the preparation of angiogenin |
| KR101760758B1 (ko) * | 2008-05-14 | 2017-07-24 | 애그리컬쳐 빅토리아 서비스 피티와이 엘티디 | 질병 및 장애를 치료하기 위한 안지오게닌 또는 안지오게닌 아고니스트의 이용 |
-
2009
- 2009-05-14 WO PCT/AU2009/000602 patent/WO2009137879A1/en not_active Ceased
- 2009-05-14 NZ NZ589306A patent/NZ589306A/xx not_active IP Right Cessation
- 2009-05-14 CN CN2009801278079A patent/CN102099050A/zh active Pending
- 2009-05-14 JP JP2011508768A patent/JP2011519960A/ja active Pending
- 2009-05-14 US US12/992,416 patent/US20110262422A1/en not_active Abandoned
- 2009-05-14 BR BRPI0911958A patent/BRPI0911958A2/pt not_active Application Discontinuation
- 2009-05-14 KR KR1020107027723A patent/KR20110033122A/ko not_active Withdrawn
- 2009-05-14 CA CA2724048A patent/CA2724048A1/en not_active Abandoned
- 2009-05-14 AU AU2009246052A patent/AU2009246052A1/en not_active Abandoned
- 2009-05-14 EP EP09745301A patent/EP2307044A4/en not_active Withdrawn
- 2009-05-14 MX MX2010012438A patent/MX2010012438A/es not_active Application Discontinuation
- 2009-05-14 RU RU2010150934/15A patent/RU2010150934A/ru not_active Application Discontinuation
-
2010
- 2010-11-11 IL IL209284A patent/IL209284A0/en unknown
- 2010-12-14 ZA ZA2010/09004A patent/ZA201009004B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011519960A5 (enExample) | ||
| RU2010150934A (ru) | Пероральный препарат | |
| RU2010150931A (ru) | Применение ангиогенина или агонистов ангиогенина для лечения заболеваний и нарушений | |
| WO2004052371A3 (en) | Cyclic quinoline compounds for use in mch receptor related disorders | |
| JP2006502162A5 (enExample) | ||
| AU2003273967A1 (en) | Use of indoleacetic acid derivatives which increase the serum igf-1 level for the preparation of a therapeutical composition for treatment of various diseases | |
| JP2005534616A5 (enExample) | ||
| US20090035306A1 (en) | Quinazolinone modulators of tgr5 | |
| CN110869024A (zh) | 多生物剂及其使用方法 | |
| WO2007050726A3 (en) | Thienopyrimidinone derivatives as melanin concentrating hormone receptor-1 antagonists | |
| NO20074117L (no) | Fremgangsmater og sammensetninger for a behandle diabetes, metabolske sykdommer og tilstander | |
| BRPI0418079A (pt) | composto, composição farmacêutica, e, usos de uma composição e de um composto | |
| JP2009286804A5 (enExample) | ||
| EP2117559A2 (en) | Pharmaceutical composition for the treatment of il-8 mediated diseases | |
| JP2017538705A5 (enExample) | ||
| MX2011013507A (es) | Nuevos agonistas del gpr 119. | |
| WO2006042152A3 (en) | Vasoactive intestinal polypeptide pharmaceuticals | |
| JP2014508758A5 (enExample) | ||
| EP3081228B1 (en) | Irisin for care and prevention of osteoporosis | |
| JP2007505883A5 (enExample) | ||
| RU2013119595A (ru) | Низкодозовая фармацевтическая композиция | |
| TW200306294A (en) | Helicobacter infection treatment | |
| JP2013511287A5 (enExample) | ||
| WO2008019062A3 (en) | Polypeptide derivatives of parathyroid hormone (pth) | |
| CN101530617A (zh) | 一种含ppar调节剂和锶盐的药物组合物 |